Genpharmasec Ltd
BSE:531592
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.93
5.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Genpharmasec Ltd
Gross Profit
Genpharmasec Ltd
Gross Profit Peer Comparison
MSTCLTD
ADANIENT
REFEX
INDIAMART
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Genpharmasec Ltd
BSE:531592
|
Gross Profit
₹61.7m
|
CAGR 3-Years
43%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
S
|
Shree Global Tradefin Ltd
BSE:512463
|
Gross Profit
₹2.4B
|
CAGR 3-Years
5 022%
|
CAGR 5-Years
167%
|
CAGR 10-Years
N/A
|
|
|
MSTC Ltd
NSE:MSTCLTD
|
Gross Profit
₹7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Adani Enterprises Ltd
NSE:ADANIENT
|
Gross Profit
₹475.5B
|
CAGR 3-Years
60%
|
CAGR 5-Years
44%
|
CAGR 10-Years
10%
|
|
|
Refex Industries Ltd
NSE:REFEX
|
Gross Profit
₹1.9B
|
CAGR 3-Years
22%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Indiamart Intermesh Ltd
NSE:INDIAMART
|
Gross Profit
₹12.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
See Also
What is Genpharmasec Ltd's Gross Profit?
Gross Profit
61.7m
INR
Based on the financial report for Mar 31, 2024, Genpharmasec Ltd's Gross Profit amounts to 61.7m INR.
What is Genpharmasec Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
75%
Over the last year, the Gross Profit growth was 191%. The average annual Gross Profit growth rates for Genpharmasec Ltd have been 43% over the past three years , 75% over the past five years .
You don't have any saved screeners yet
